STK11 and myeloproliferative disorder: LKB1, also known as serine-threonine kinase 11 (STK11), has been identified as a tumor suppressor in various cancers, including gastrointestinal, non-small cell lung, pancreatic, cervical, and myeloproliferative neoplasms [34, 35].